GlaxoSmithKline and the University of Leicester in the U.K. will collaborate to discover and develop novel medicines to treat high-grade non-Hodgkin’s lymphoma. The project is part of GSK’s Discovery Partnerships with Academia initiative. Professor Simon Wagner, from the Department of Cancer Studies, who is leading the project on behalf of the University of Leicester, said:...
The Biden administration has left NIH in a weakened state, intensifying politicization of science on Capitol Hill and eroding the bipartisan support the government’s premier biomedical research agency has traditionally enjoyed.
